Načítá se...
Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes
In the past, patients with hemophilia and inhibitors have had less-than-optimal treatment and have experienced more orthopedic complications than patients without inhibitors. Bypassing agents offer the potential to close treatment gaps between inhibitor and noninhibitor patients by helping the forme...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110812/ https://ncbi.nlm.nih.gov/pubmed/25083214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098611415566 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|